Correlation Between Oncopeptides and Genovis AB
Can any of the company-specific risk be diversified away by investing in both Oncopeptides and Genovis AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncopeptides and Genovis AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncopeptides AB and Genovis AB, you can compare the effects of market volatilities on Oncopeptides and Genovis AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncopeptides with a short position of Genovis AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncopeptides and Genovis AB.
Diversification Opportunities for Oncopeptides and Genovis AB
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Oncopeptides and Genovis is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Oncopeptides AB and Genovis AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genovis AB and Oncopeptides is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncopeptides AB are associated (or correlated) with Genovis AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genovis AB has no effect on the direction of Oncopeptides i.e., Oncopeptides and Genovis AB go up and down completely randomly.
Pair Corralation between Oncopeptides and Genovis AB
Assuming the 90 days trading horizon Oncopeptides AB is expected to under-perform the Genovis AB. In addition to that, Oncopeptides is 1.39 times more volatile than Genovis AB. It trades about -0.05 of its total potential returns per unit of risk. Genovis AB is currently generating about 0.0 per unit of volatility. If you would invest 4,240 in Genovis AB on August 29, 2024 and sell it today you would lose (1,500) from holding Genovis AB or give up 35.38% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oncopeptides AB vs. Genovis AB
Performance |
| Timeline |
| Oncopeptides AB |
| Genovis AB |
Oncopeptides and Genovis AB Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oncopeptides and Genovis AB
The main advantage of trading using opposite Oncopeptides and Genovis AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncopeptides position performs unexpectedly, Genovis AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genovis AB will offset losses from the drop in Genovis AB's long position.| Oncopeptides vs. Hansa Biopharma AB | Oncopeptides vs. BioArctic AB | Oncopeptides vs. Sinch AB | Oncopeptides vs. Cantargia AB |
| Genovis AB vs. Systemair AB | Genovis AB vs. Upsales Technology AB | Genovis AB vs. FormPipe Software AB | Genovis AB vs. White Pearl Technology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |